Cassava Sciences vs. Biogen
Mighty Biogen (NASDAQ:BIIB) is a massive biotech, weighing in at $50 billion (market cap). Tiny Cassava Sciences (NASDAQ:SAVA) is less than one-tenth the size, with a valuation of $4 billion. Both companies are pursuing Alzheimer’s drugs.
Alzheimer’s is…
